Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among Postmenopausal Women Already Treated with at Least 5 Years of Endocrine Therapy By Ogkologos - August 25, 2025 634 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a meta-analysis performed by the Early Breast Cancer Trialists’ Collaborative Group Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Colorectal Cancer Screening: Where Does the Shield Liquid Biopsy Fit In? October 11, 2024 Aiming to Prevent Cancer Cases, ESMO Campaigns Against the Use of... September 17, 2025 Many Older Adults Screened Unnecessarily for Common Cancers August 27, 2020 Selpercatinib Shows Durable Efficacy in RET-Altered Thyroid Cancer August 28, 2020 Load more HOT NEWS What is De-escalation Treatment in Cancer Research? EMA Recommends Extension of Indications for Talazoparib Similar Median OS Between Ripretinib versus Sunitinib in Patients with Advanced... Investment Needed to Bring Down Pancreatic Cancer Death Rates in Europe....
